Charitable medication distribution improves care for uninsured patients with diabetes.

Objectives: This study examined the impact of insulin products donated by a pharmaceutical manufacturer and dispensed by Dispensary of Hope-partnered pharmacies on medication access and treatment outcomes among uninsured patients with type 2 diabetes (T2D).

Study Design: This was a pilot, single-center, retrospective observational study.

Methods: Uninsured patients with diabetes who were newly established with Ascension Medical Group clinics for the treatment of T2D were included in this study.

Collateral status, hyperglycemia, and functional outcome after acute ischemic stroke.

Background: Mixed data exist regarding the association between hyperglycemia and functional outcome after acute ischemic stroke when accounting for the impact of leptomeningeal collateral flow. We sought to determine whether collateral status modifies the association between treatment group and functional outcome in a subset of patients with large vessel occlusion enrolled in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.

Methods: In this post-hoc analysis, we analyzed patients enrolled into the SHINE trial with anterior circulation large vessel occlusion who underwent imaging with CT angiography prior to glucose control treatment group assignment.